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The term spreading factor was originally employed to describe a property
present  in  testicular  tissue  and  sperm  which  is active  in enhancing  bac-
terial and virus infections.  Subsequently the use of the term was extended
to describe the  same or a  similar property present  in various  tissues,  bac-
teria, and other material, which is responsible for the spreading of solutions
of dyes and toxins in  the skin of experimental  animals.
Hyaluronidase  is  the  term  which  has  been  given  to  the  enzyme  re-
sponsible  for  the  hydrolysis  of  hyaluronic  acid,  an  acid  polysaccharide
which  has been isolated from  a variety  of  human and animal  sources.
Spreading Factor.-In  1928 Duran-Reynals  (1) demonstrated  that normal  testicular
tissue increases  the infective power of neurovaccine.  In the following year he reported
(2)  that the infectivity of neuro-, testicular, and cow strains of vaccine virus is enhanced
to an extraordinary  degree by contact with sensitive tissues of susceptible animals.  He
further reported  that this effect was due  to  the presence of an  extractable  factor  which
exerted  a  similar  influence  on  many  viruses  and  organisms.  Later  Hoffmann  and
Duran-Reynals  (3) demonstrated  that spreading factor  induces a spreading  of solutions
of  dyes  and  toxins  injected  intracutaneously  into  experimental  animals.  They  at-
tributed  the  phenomenon  to  the  capacity  of  the  injected  material  to increase  tissue
permeability  (3, 4).
In the following  years the phenomenon  of spreading  and the properties  of spreading
factor  were  studied  by  Duran-Reynals  and  a  large  number  of  other  investigators.
Spreading  factor has been demonstrated  in extracts of invasive bacteria;-Staphylococcus
aureus, Streptococcus hemolyticus, Clostridium welckii,  Cl. chauvei, Cl.  oedematis-maligni,
pneumococcus,  and  other  bacteria  (5);  in  certain  malignant  tumors  (6);  in  snake  and
other animal venom  (7);  and in  leech  extracts  (8).  Likewise,  Claude  has  shown  that
certain  azoproteins  possess  a  similar  property  (9).  The  mechanism  of spreading has
also been studied by several investigators.  McClean  (10) has shown that the phenome-
non  occurs  when  injections are made  in the  isolated skin  of  a rabbit.  Favilli  (11),  as
well as Duran-Reynals  (12),  has further  shown that the same phenomenon can be demon-
* This work has been  supported in part by a grant from the John  and Mary Markle
Foundation.
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strated  in muscles, tendons,  and in the walls of stomach and intestine.  Finally Duran-
Reynals  has shown  (4)  that the permeability  of the vascular  system can  be locally or
generally  increased  by means  of preparations  rich in spreading factor.
Hyaluronidase.-Hyaluronic  acid is an acid polysaccharide  of high molecular  weight
which  is  composed  of  acetyl-glucosamine  and glucuronic  acid  in  equimolar  concentra-
tions.  It has been isolated from the following  sources:  vitreous  humor (13),  umbilical
cord (14),  the mucoid phase  of group A hemolytic streptococci  (15),  synovial fluid (16),
fowl  sarcoma  (17), and the pleural fluid  of a patient  with a mesothelioma  (18).  Hyal-
uronic  acid  forms viscous  solutions  and  the  mucinous  character  of  the  material  from
which it has been  isolated  is due to the presence  of this  constituent.
An  enzyme  or  enzymes  which  decrease  the  viscosity  of solutions  containing  hyal-
uronic  acid,  with  the  liberation  of  reducing  substances,  has  been  prepared  from  the
following sources: two strains of pneumococcus, one strain of group A hemolytic strepto-
coccus, one strain of CI. wekhii, and from splenic tissue (19).  Such enzyme preparations
specifically  hydrolyze  isolated  hyaluronic  acid,  and  the  enzyme  has  been  therefore
designated  as  hyaluronidase.
In a recent paper Chain and Duthie  (20) reported that testicular extracts
decrease  the  viscosity  of  synovial  fluid  and  vitreous  humor,  with  the
liberation  of  reducing  substances.  Since  such  extracts  also  induce  the
phenomenon  of  spreading  these  investigators  suggested  that  spreading
factor  is  probably  identical  with  the  "mucinase"  which  hydrolyzes  the
polysaccharide  in  these  fluids.  Meyer  and  Chaffee  (21)  confirmed  the
observations  of  Chain  and  Duthie  and,  in  addition,  demonstrated  that
testicular  extracts  hydrolyze  isolated  hyaluronic  acid.  Claude  (22)  in  a
study of leech  extracts also contributed evidence  in support of the theory
proposed  by Chain and Duthie.  He  showed that such material, which  is
rich in spreading factor, contains a "mucolytic"  enzyme which reduces the
viscosity  of  Chicken  Tumor I extracts  and  of  a  "mucoprotein"  isolated
from  skin.  He  concluded  that the  strength  of  the  "mucolytic'  enzyme
paralleled  the  strength  of  spreading  factor  and  suggested  that  the  two
agents might  be  identical.  The present  study  was  undertaken  to deter-
mine  more precisely  the relationship  between  spreading factor  and hyalu-
ronidase.  Some of the results have already been published in a preliminary
communication  (23).
EXPERIMENTAL
The presence  of hyaluronidase and spreading factor was tested in prepa-
rations  from  the  following  sources:  pneumococci  (Type  I,  virulent  and
avirulent  strains;  Type II, avirulent  strain),  group  A  hemolytic  strepto-
cocci (virulent and avirulent strains in the mucoid, matt, and rough phases
(24)),  Cl. welchii, testis, pigskin,  leech extract,  commercial  spleen extract,
commercial  hirudine,  and  certain  chemical  substances.
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Methods
Spreading Factor.-The spreading  capacity  of  the  various preparations  was  tested
by the intradermal method using  the  dye T.1824.  The substances  to  be tested  were
dissolved in saline and 0.125 cc. of the test solution was mixed with an equal volume of a
2  per  cent  aqueous  solution  of  the  dye.  The  resultant  mixture was  injected  intra-
dermally into male albino rabbits weighing 4.5 to 5.5 pounds.  The area  of diffusion  was
measured at 3 hours and 20 hours after injection.  Four  injections were made on each
rabbit,  using  only the area  between  the fore and  hind limbs  on each side.  A mixture
of 0.125  cc.  of saline and an equal volume of dye was used as a control  in each rabbit.
Individual  animals  were  found  to  vary  considerably  in  their  skin  permeability.  In
order to eliminate  error  due to  this  variation,  an  index  of diffusion  was  determined,
according to the method of Claude  (8), by dividing the area of spread produced  by the
test solution  by the  area  of spread  produced  by the  saline control.  Only  an index of
1.4 or more was accepted as an indication  of  spread.  An index  of  1.1  to 1.3  was  con-
sidered doubtful and 1.0 or less negative.
Hyaluonidase.-Hyaluronidase  preparations  were  made  according  to the procedure
described  in  an  earlier paper  (19).  The action  of hyaluronidase  was  tested  (a) by the
hydrolysis of isolated hyaluronic  acid and  (b) by determining changes in the viscosities
of various fluids  known  to contain hyaluronic  acid.
Hydrolysis of the polysaccharide  was carried out as follows:  0.1  mg. of the powdered
enzyme  preparation  was  incubated  at 37°C.  with 5  mg.  of  the  polysaccharide  in  the
presence of toluene at pH 5.8.  Loss of the viscosity of the solution was observed almost
immediately.  Reducing values were determined  after  2 hours,  20 hours,  and 44 hours.
Reducing  sugar  was  determined  by  the  ceric  sulfate  method  (25).  The  theoretical
reducing  value  of a given preparation  was calculated  from the  acetyl-glucosamine  and
glucuronic  acid  content  as  determined  by  analysis  and  expressed  as  equivalents  of
glucose.
Change in viscosity  was determined by means of the Ostwald viscosimeter.  Viscous
pleural fluid  obtained from a patient  with a mesothelioma  of the  pleura  was used as  a
test material.  It  had previously been  shown  that  the viscosity  of the fluid was due to
the presence of hyaluronic acid  (18).  5  cc. of the pleural fluid were incubated  at 37°C.
with  1 mg. of enzyme preparation  dissolved in 0.1  cc.  of water.  Readings  were made
at  varying  intervals  and  the  results  interpolated  graphically.  A  control experiment
with 5 cc. of the pleural fluid plus 0.1  cc. of 0.9 per cent sodium chloride served as control.
The  recorded  values  were  expressed  as  per cent  reduction  of  viscosity relative  to  the
viscosity of 0.9 per cent sodium chloride.
The  relation  between  the  two  reactions,  hydrolysis  and  decrease  in  viscosity,  is
discussed  in detail elsewhere  (26).  It  is sufficient  to state  at this  point that  although
the two reactions apparently are catalyzed  by the same agents,  it has not  been proven
conclusively  that they are due to the same enzyme.
Experimental  observations  suggesting  a  relationship  between spreading
factor  and  hyaluronidase  will  first  be  presented.  Following  this certain
findings  and observations  suggesting  dissimilarities  between  the  two  will
be  reported.SPREADING  FACTOR  AND  HYALURONIDASE
I.  Similarities  between Spreading Factor and Hyaluronidase
1.  The Presence of Spreading Factor in All Preparations  Containing Hy-
aluronidase.-Preparations  of hyaluronidase  were made from the following
sources:  pneumococcus  (Type  I virulent,  strain  1/230;  Type  I avirulent,
strain  1/192/R);  group  A Streptococcus hemolyticus (type 4,  strain H 44);'
TABLE  I
Presence of Spreading Factor in Preparations  Containing Active  Hyaluronidase
Spread  Hydrolysis
Source of preparation  Average  Enzyme
Amount  index of  concentra-  2 hrs.  20 hrs.
injected  spread  tion
mg.  per ces  per cent  per cent
Hemolytic streptococcus
Strain H 44, preparation  1  3.1  2.6  0.5  7  12
"  "  2  2.5  2.4  5  8
......  3  5.0  2.8  6  39
Pneumococcus
Strain 1/230  3.2  4.3  0.05*  28  59
1/192/R  3.0  3.3  I  "  26  60
"  D/39/R,  preparation  1  5.0  6.0  68  92
"  2  3.0  6.3  "  *  51  62
I  3  2.5  3.6  11  54
"  4  1.3  10.0  23  55
Cl. welchii
Strain Lister A  2.3  3.4  0.25  44  74
Testis
Preparation  1  0.7  3.1  0.5  42  47
"  2  3.8  1.4  20  38
Leech  (dried)  1.25  2.5  0.25  37  67
* These  preparations  of  enzyme  also  produced  a  reduction  of
mately 90 per cent within  10 minutes.
viscosity  of  approxi-
Cl.  welchii  (Lister  A  strain);  crude  leech  extract;2  and  testicular  extracts
prepared  according  to  the methods of  Morgan  and  McClean  (27)  and  of
Duran-Reynals  (4).  When  tested  by  the  methods  previously  described
all  the foregoing  preparations  were  found  to  possess  the  capacity  of  hy-
' Attempts  to obtain  hyaluronidase from other strains of group A hemolytic  strepto-
cocci have so far proved unsuccessful.  The strain employed (H 44) produces only matt
colonies and it seems possible  that its  failure  to produce  mucoid  colonies  may  be due
to the presence  of the enzyme.
2 We are indebted to Dr.  Claude for a generous supply of leech extract.
112G.  L.  HOBBY,  M.  H.  DAWSON,  K.  MEYER,  AND  E.  CHAFFEE
drolyzing  hyaluronic  acid.  Similarly  when  tested  for  the  presence  of
spreading  factor  all preparations  were  found  to  produce  marked  spread-
ing.  However,  no parallelism  was  observed  between  the  strength  of  the
spreading  factor  and  of  the  enzyme  from  the  same  preparations.  The
results are summarized in Table I.
TABLE  II
Effect  of Heat on Spreading Factor
Average index of  spread
Source of preparation  Amount injected
Unheated  Heated at 65C. for 30 min.
sag.
Pneumococcus  (strain D/39/R)  5.0  6.0  3.6
Preparation  1  3.0  6.3  3.4
2.5  5.6  2.2
0.25  3.0  1.1
0.06  2.3  1.2
Unheated  Heated at 100C.
for 30 min.
Preparation  2  2.5  4.9  2.0
Unheated  Heated at 65'C. for 30 m/n.
Hemolytic streptococcus  8.6  6.5  4.3
(strain H 44)  5.0  2.8  2.6
3.1  2.6  1.8
2.5  2.4  1.6
0.5  2.4  1.4
0.25  2.0  <1.0
0.06  1.7  <1.0
Heated at 100C.
for 30 min.
2.5  2.3  1.4
2.  Effect of Heat on Spreading Factor and Hyaluronidase.-Preparations
made  from pneumococcus  and  Streptococcus hemolyticus were  dissolved  in
physiological  saline and heated  at 65°C.  for 30 minutes  and at  100°C. for
the same period.  The activity of  the heated material  was then  compared
with  that  of  the  unheated.
After heating at 650C. for 30 minutes the activity of the spreading factor
was  diminished  but not completely  destroyed.  Heating  at  100°C.  for 30
minutes  produced  a  similar  effect  (Table II).  The  effect  of  heat  on
hyaluronidase  is shown  in  Table III.  In  one  experiment  the  activity  of
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the enzyme  was  markedly weakened  by heating  at  65°C.  for 30  minutes
and in the second experiment  it was destroyed entirely.  Similarly heating
at 100°C.  for  30 minutes completely  inactivated  the enzyme.
TABLE  III
Effect of Heat on Hyaluronidase
Enzyme  Hydrolysis,  per cent
Source of preparation  concentra-
tionUnheated  Heated  at 65C.  for
30 min.
per cet  2 hrs.  20 hrs.  2 hrs.  20 hrs.
Pneumococcus  (strain  D/39/R)
Preparation  1  0.05  40  62  5  37
Unheated Unheated  Heated  at 100'C. for 30 min.
2 hrs.  20  rs.  2 hrs.  20 hrs.
Preparation 2  0.1  22  59  0  0
Unheated Unheated  Heated  at 65'C. for 30 min.
2  hrs.  20 hrs.  2  hrs.  20hrs.
Hemolytic streptococcus  (strain H 44)  0.5  6  21  0  2
TABLE  IV
Effect of Iodine on Spreading Factor  and Hyaluronidase*
Average  index of spread  Inhibition of hydrolysis, per cent
Source of preparation
Before  treat-  After  treat-  Before treat-  After treat-
ment with Is  ment with Is  ment with Is  ment with 12
Pneumococcus,  strain D/39/R
Preparation  1  2.0  1.7  0  100
"  2  4.0  1.7  0  100
*In  these  experiments  0.25  cc.  N/10  iodine  was  used.  Under  the  experimental
conditions  neither  spreading factor  nor hyaluronidase  was reactivated  by N/10 sodium
sulfite.  In  later experiments  it was found that by using lower concentrations of  I2 the
inactivation of  hyaluronidase  could be reversed by As2O 3.
3.  Inactivation of Spreading Factor and  Hyaluronidase by  Iodine.-A
preparation  of  hyaluronidase  from pneumococcus  was  made  up  in  a con-
centration of  20 mg. per cc.  To  0.5 cc. of  this  solution was  added 0.25 cc.
of N/10 iodine  and, after  10 minutes,  0.25  cc.  of N/10  sodium  sulfite.  As
a  control,  0.5  cc.  of  the enzyme  solution was diluted with 0.5  cc.  of physi-
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ological  saline.  The  resultant  mixtures  were  tested  for  hyaluronidase3
and for spreading power.  As indicated  in Table IV the activity of spread-
ing factor was greatly  reduced by  iodine while  the activity of  the enzyme
was completely destroyed.  Under the conditions of the experiment, neither
was  reactivated  by sodium  sulfite.4
4.  Presence of Hyaluronic Acid  in Skin.-The  theory  that  spreading
factor  is  identical  with hyaluronidase  postulates  the  presence  in  skin  of
either hyaluronic  acid  itself, or a related  substrate,  upon which hyaluron-
idase may act.  Recently  in this laboratory  an acid polysaccharide  which
exhibits  all  the properties  of  hyaluronic  acid  has been  isolated  from pig-
skin.  The method  of  preparation  and  the  analytical  data pertaining  to
this  polysaccharide  are  being  presented  in  detail  elsewhere  (28).  This
skin polysaccharide  has  the  same  optical  rotation  and  is hydrolyzed  by
hyaluronidase  at  the  same  rate  as  hyaluronic  acid  obtained  from  other
sources.  The demonstration  of hyaluronic  acid in  skin  is consistent with
the theory that the spreading phenomenon  is due to the enzymatic  hydrol-
ysis of this polysaccharide.
II.  Dissimilarities  between Spreading  Factor and Hyaluronidase
1.  The Presence  of Spreading  Factor  in Preparations  in Which Hyaluroni-
dase Has Not Been Demonstrated.-It  has already been reported that a num-
ber of preparations made from strain H 44 of group A hemolytic streptococ-
cus possessed  both spreading factor and the ability to hydrolyze hyaluronic
acid.  Certain other preparations  made  from strain H 44 as well  as from
other  strains  of  group  A  hemolytic  streptococci  failed  to  hydrolyze
hyaluronic  acid  although  they did  possess  spreading  factor.  The  results
of nine  experiments  are  summarized  in Table  V.  Marked  spreading  was
obtained with eight of the nine preparations yet none hydrolyzed hyaluronic
acid.  So,  also, a preparation from strain 6163 of Cl. welchii, received  from
Dr. Fritz  Schiff, contained  no demonstrable hyaluronidase  but did produce
marked  spreading.
Other  substances  tested  for  the  presence  of  spreading  factor  and  hy-
aluronidase  were as follows: commercial  hirudine  (Eimer and Amend Com-
pany);  a  commercial  preparation  of  beef-spleen  (Armour  spleen liquid  40
per cent) which had been concentrated  10 times by drying in vacuo; a prep-
' Due  to difficulties  encountered  with  the  ceric  sulfate  method  in  the  presence  of
iodine and the reducing agents,  the liberated reducing groups  in this case were measured
by  the  Folin-Wu  method.
4In  subsequent  experiments  it  was  found  that  by  using  lower  concentrations  of
iodine  the inactivation  of hyaluronidase  could be reversed  by arsenious  oxide.
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aration from pigskin; two azoprotein preparations; arsenious oxide in 0.025
and 0.0025  molar  concentrations;  and,  finally,  isolated  hyaluronic  acid it-
self.  As  indicated  in  Table  V  none  of  these  preparations  hydrolyzed
hyaluronic  acid  but all  were  capable  of  inducing  spreading phenomena.
In interpreting  the spreading phenomena induced by these various  agents considera-
tion must be  given both to  the rate and to the type of reaction.  Madinaveitia  (29) has
TABLE  V
Presence of Spreading Factor in Inactive Hyaluronidase Preparations  and in Other
Material  Which Does Not Contain Hyaluronidase
Material injected
A.  Inactive hyaluronidase preparations
Hemolytic streptococcus
Strain H 44, preparation  1
"  C203MV  "  1
I  el  I'  2
"  C203R
"  Render  "  1
Cl. welchii, strain 6163
B.  Other material which  does not contain
hyaluronidase
Azoprotein,  preparation  1
"  2
Hyaluronic acid
Hirudine
Pigskin
Spleen extract (10  X conc.  soln.)
Arsenious oxide 0.05 aM
4"  "  4  0.005 M
Amount  injected
mg.
3.0
1.0
3.5
1.0
3.2
3.2
2.2
3.4
0.5
0.25
1.2
2.8
2.6
3.3
CC.
0.125
0.125
0.125
Average index
of  spread
2.4
3.1
2.4
3.0
6.5
5.5
4.5
2.4
2.0
1.4
15.5
1.9
2.2
1.5
2.1
3.3
1.5
Hydrolysis
per  cost
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
called attention to the difference  in the rate of spread produced by kallikrein compared
with that induced by testicular extracts and other preparations.  While all preparations
were  effective in  causing  spread he found that the rate of the reaction  was much slower
with  kallikrein  than  with  the  other  agents  tested.  He  therefore  inferred  that  the
mechanism of the reaction was not the same in  both instances.  Claude  (30) has  called
attention to a  difference in  the type of  spreading reaction  produced  by various  agents.
According to him there is more thickening and edema of the skin in the area of the spread
with  arsenious  oxide  than  with leech  extract.  The  type  of  reaction produced  by  azo-
proteins  is  intermediate  between  these  two.
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The  observations  of Madinaveitia  and  of  Claude  indicate  that great  care  must  be
taken in interpreting  spreading  phenomena  in general.  The test is purely a biological
one  and subject  to many variations.  Except in the experiments  with arsenious  oxide
we were unable  to detect any significant  differences  in  either the rate  or the  character
of the reaction.  However, readings  were only made at  the end of 3 and 20 hour periods
and no  histological  studies  of the skin  were  made  in  the  tested areas.  It is therefore
possible that future  studies  will show that spreading is not a single  phenomenon  but a
group  of reactions  depending  upon  a variety  of mechanisms,  one  of  which  may be the
hydrolysis  of hyaluronic acid.
2.  Effect of A ntisera to Hyaluronidase  Preparations  on Hyaluronidase  and
on Spreading Factor.-The  following experiments were undertaken  in order
to  determine  whether  hyaluronidase  preparations  were  antigenic,  and  if
so,  whether  the antisera  so prepared  would  exert  the same  effect  on  the
hyaluronidase  and  on  the spreading  factor known  to  be  present  in  these
preparations.
(a) Precipitation  of Hyaluronidase  Preparations  by Antisera.-
Preparation  of Antisera.-50  mg. of a sodium flavianate preparation  of pneumococcus
hyaluronidase were dissolved in 24 cc. of physiological  saline and 1  cc. of alum was added.
Four rabbits were injected 3 times a week for a period of 4 weeks.  Each animal received
a total of  110 mg. of enzyme preparation.  The rabbits were bled on the 6th day follow-
ing  the last  injection.
Antisera  so prepared  were set up against the homologous hyaluronidase
preparations  as  well  as  against  hyaluronidase  preparations  made  from
Streptococcus hemolyticus and  Cl. welchii.  In  the case  of the homologous
enzyme preparations  definite  precipitates  were  obtained  with  amounts of
1.0 and  0.1  mg. per cc.  Weaker reactions were  obtained  with the prepa-
rations from  Streptococcus hemolyticus  and  no  reaction  with  preparations
from Cl. welchii.  The results are summarized in Table VI.
The  results of  these  experiments  show that  the hyaluronidase  prepara-
tions made  from  pneumococcus  possess  antigenic  properties.  However,
the  fact  that  weak  or  no precipitation  was  obtained  with  heterologous
enzyme  preparations  suggests that the precipitation  obtained  with homol-
ogous  preparations  might  well  have  been  due  to  extraneous  antigenic
material present in the pneumococcal  hyaluronidase preparation.
(b)  Effect  of Antisera to  Hyaluronidase Preparations  on  Hyaluronidase
Activity.-
The capacity of  antisera to inhibit  the activity of hyaluronidase prepa-
rations was tested as follows:-
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Samples  of each  of the antisera above described were  precipitated by half saturation
with sodium sulfate at 350C. and the precipitate dissolved in water to the original volume.
0.1  cc.  of  each antiserum  fraction was  mixed with  0.1  mg.  of enzyme  preparation  and
5 mg. of hyaluronic acid.  The mixture was incubated at 370C. at pH 5.8 and the amount
of  hydrolysis  determined  after  2 and  20  hours.  Controls  were  set  up  in  which  the
antiserum fraction was replaced by normal rabbit and normal human sera.
TABLE  VI
Precipitin Reactions with  Various Enzyme Preparations  and Antisera against
Pneumococcal Hyaluronidase
Antiserum
No.
1
2
3
4
Dilu-
tion
O
O
O
O
Control
Control ...........
Enzyme  preparation
Pneumococcus
1
mg./
cc.
Ring
++Ring
Ring
Ring
Ring
0.1
mg./
cc.
I -
0.01
mg./
cc.
0.001
mg./
cc.
0.0001
mg./
cc.
Hemolytic  streptococcus
0.1  0.01
mg./cc.  rc!  /  MgC/
cc.  · CC.
Cloud
++
Cloud
+
Ring
Ring
t
CI.  welchii
1  0.1  0.01
mg./  mg./  Img./
cc.  cc.  cc.
±
-
The tests were  read after 30 minutes at room temperature  and the presence  of rings
or clouding  noted.  The tubes were then  shaken, incubated at  37C. for  1i hours,  and
stored in the refrigerator overnight.  Final readings  were made after refrigeration.
The results in Table VII  show that three of the four antisera completely
inhibited  the activity of  the homologous hyaluronidase  preparations  while
the fourth caused  over 80 per cent inhibition.  On the other hand, only 25
to  50 per cent inhibition was observed  when the same antisera were  tested
against heterologous  hyaluronidase  preparations made  from Streptococcus
hemolyticus and Cl. welchii.  Control  experiments  showed  that normal hu-
man  and normal  rabbit  serum  exerted  approximately  the same  degree  of
inhibition.  It  is  therefore  concluded  that antiserum  inhibits the activity
of  the homologous  hyaluronidase  preparation but exerts little  or no  effect
on  heterologous  preparations.
In interpreting the results  of this experiment  attention  is directed to two complicat-
ing factors.  In the first place the inhibition of the activity of the hyaluronidase prepara-
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tion exhibited by the homologous antiserum may be due, in part at least, to the adsorp-
tion of the active material  on an extraneous precipitate,  rather than an actual antibody
inhibition.  Secondly  the  inhibition  produced  by  normal  human  and  normal  rabbit
serum may be due  to the salt formation  which  takes place between  the serum protein
and hyaluronic acid at the pH of the experiment.
TABLE  VII
Effect of Hyaluronidase Antisera on Hyaluronidase  Activity
Hyaluronidase activity-hydrolysis,  per cenr
Antiserum to hyaluronidase
(pneumococcus)  Pneumococcus  Streptococcus  Cl. welchii
2 hrs.  20 hrs.  2 hrs.  20 hrs.  2 hrs.  20 hrs.
No serum  26  86  7  42  10  61
Normal rabbit serum  14  69  8  31  4  27
Antiserum  1  3  14  12  39  1  30
2  0  2
t  3  0  2
"  4  1  1  7  33  6  33
TABLE  VIII
Effect of Hyaluronidase  Antisera on Spreading Factor
Antineum  to hyaluronidascoccus)  Source of spreading factor  Average  index of spread
No serum  Pneumococcus  1.5
Antiserum  "  1.8
No serum  Streptococcus  5.6
Antiserum  "  5.6
(c)  The  Effect  of Antisera to  Hyaluronidase Preparations  on Spreading
Factor.-
The  effect  on  spreading  factor  of  antisera  made  against  pneumococcal
and  streptococcal  hyaluronidase  preparations  was  tested  as  follows:-
0.25  cc.  of  each  of  two  enzyme  preparations  containing  10  to  12  mg.  per cc.  was
mixed with  equal volumes  of antiserum.  The resultant  mixture  was injected immedi-
ately  into  the  skin of rabbits and  again  after  the material  had been  allowed  to  stand
for  2 hours  at room  temperature.  Serum  mixed  with  an  equal volume  of water  was
used as a control.
The results presented in Table VIII show that antisera  to hyaluronidase
preparations did not affect the spreading property of either the pneumococcal
or the streptococcal  preparations.  These results differ from those reported
in  the  preceding  section  in  which  it  was  shown  that  the  same  antisera
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did inhibit  the activity  of homologous  hyaluronidase  preparations  in vitro.
Therefore, as far as the capacity of antisera to inhibit their respective effects
is  concerned,  there  appears  to  be  a  distinction  between  spreading  factor
and  hyaluronidase.  Whether  this  difference  is  real  or  only  apparent  is
considered  in  the general  discussion.
DISCUSSION
Since  spreading factor is not as yet  a precisely  defined  agent it is obvi-
ously  impossible  to  express  any  final  opinion  as  to  its  identity  or  non-
identity  with hyaluronidase.  In the present  study  an attempt  has been
made merely to determine  a possible relationship between the phenomenon
of  spreading and hyaluronidase  activity.  A comparison  of  the properties
of the  two reactions  has resulted  in  the demonstration  of many points of
similarity  and,  at  the  same  time,  certain  apparent  points  of  difference.
It has been  shown  that  all preparations  containing  hyaluronidase  also
contain  spreading  factor.  It  has  likewise  been  shown  that  spreading
factor  and  hyaluronidase  possess  certain  properties  in  common.  Both
are weakened by heating at 650C. for 30 minutes and their activity is almost
entirely  destroyed  by  heating  at  100°C.  for  the  same  period.  Both  are
partially inactivated by iodine, and, under the conditions of the experiment,
neither is reactivated  by sodium sulfite.  An even more significant fact in
establishing  a possible  relationship  between  the two  has been the demon-
stration of the presence  of hyaluronic  acid in skin.  The occurrence  of this
substrate  in  skin offers  a plausible  explanation  for  the  mechanism  of the
spreading  phenomenon.
On  the other hand  certain  evidence  has been  presented  indicating  that
the phenomenon  of spreading  is not identical with hyaluronidase  activity.
Many preparations  which possessed  no hyaluronidase  activity were shown
to  exhibit  marked  spreading  properties.  So  also  an  apparent  difference
was  demonstrated  in the inhibition  of  the  activity  of  the  two  agents  by
antisera.  Antisera  made  against  pneumococcal  hyaluronidase  prepara-
tions  specifically  and completely  inhibited the  activity of  the homologous
enzyme  but did  not inhibit  the spreading  property  of  these preparations.
In  considering  the  apparent  differences  between  spreading  and  hyal-
uronidase  activity certain  facts should be borne  in mind:
1. It is possible  that  spreading  may be  due to  several  agents  of which
hyaluronidase  may  be  one.  That  more  than  one  spreading  factor  may
exist  has  been  implied  by  several  investigators.  Duran-Reynals  and
Stewart  (6)  observed  a  lack  of  parallelism  between  the  enhancement  of
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experimental  vaccinia  infections  and  the  spread  of  dyes;  Medinaveitia
(29)  called attention  to the difference in the rate of spreading produced by
different  types of agents;  Claude  (30)  pointed  out that the nature of  the
spreading  reaction was not the same in all instances; finally,  in the present
study,  it  has been  shown  that hyaluronic  acid  itself  acts  as  a  spreading
agent.  It would therefore  appear  probable  that spreading is not a  single
phenomenon  but a group of reactions depending  upon a variety of mecha-
nisms,  one of  which may be hyaluronidase  activity.
2.  The observed  differences in the effect of  antisera on spreading factor
and  hyaluronidase  also  require  some  comment.  It  is  possible  that  the
apparent  difference  may be due to the fact that the demonstration  of hy-
aluronidase activity is carried out in vitro while that of spreading is shown
in vivo.  In the former case the antiserum may combine with hyaluronidase
to form  a  loose inactive  complex  which  dissociates  to  an  active  form in
vivo.
The theory that spreading factor is adsorbed onto an extraneous precipi-
tate has been advanced by Duran-Reynals  (31)  to account for the inactiva-
tion of  spreading  factor  by antisera  to testicular  extracts.  The  evidence
available  indicates  that hyaluronidase  is  not inactivated  by such  adsorp-
tion.  Its  inhibition  by  antisera  to  homologous  enzyme  preparations,
therefore, probably cannot be explained on  this basis.
3.  The apparent  differences  between  the  two  agents may  be explained
by the greater  sensitivity  of  the test  for spreading  factor.  It  is  possible
that the intradermal  test may detect the presence  of an agent in amounts
too small to be demonstrated  by the hydrolysis  and viscosity experiments.
Although  this possibility  cannot be  denied,  the lack  of parallelism  in  the
activity of many preparations  makes such  an  explanation  improbable.
Another  finding  which  complicates  the  interpretation  of  spreading
phenomenon  is the demonstration that extracts of skin itself contain spread-
ing  factor.  This  observation,  which  was  made  by  Duran-Reynals,  has
been confirmed in the present study.  There is thus always  the possibility
that the  spreading  effect  may  be due  to the release  of  this factor  by the
injected material,  whatever it may be.  Such an explanation may  account
for the spreading produced  by simple chemical substances such as arsenious
oxide.
In  conclusion  certain  evidence  suggests  that  hyaluronidase  may  play
an important r6le  in the spreading reaction.  It  is apparent, however, that
the phenomenon  is a  complex one  and  that the entire  mechanism  cannot
be explained on the basis of a simple chemical reaction.
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SUMMARY  AND  CONCLUSIONS
A comparative  study  of spreading  factor  and hyaluronidase  in prepara-
tions from various  sources  revealed  the following points  of  similarity  and
dissimilarity in the two reactions.
1. Similarities:  (a)  All preparations  containing  hyaluronidase  also  pro-
duced spreading.  (b) Heating at 650  and 100°C.  for 30 minutes produced
a comparable effect on both reactions.  (c) The demonstration  of the pres-
ence of hyaluronic  acid in skin offers a plausible explanation for the mecha-
nism of spreading on the basis of hyaluronidase activity.
2.  Dissimilarities:  (a)  No  parallelism  was observed  in the  degree of  ac-
tivity  of  spreading  factor  and  hyaluronidase  in  the  same  preparations.
(b)  All  preparations  which  produced  spreading  did  not  contain  hyal-
uronidase.  (c)  Antisera  to  hyaluronidase  preparations  specifically  and
completely  inhibited  the  activity  of  the homologous  enzyme  but did not
inhibit the spreading factor in  the same preparations.
The  significance  of  the  similarities  and  dissimilarities  between  the  two
reactions is discussed.  It is concluded  that while hyaluronidase  may play
a  r61le  in  the  spreading  reaction  the  phenomenon  is  a  complex  one  and
cannot be explained  on the basis  of  a simple chemical  reaction.
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